← Back to headlines
Incyte Makes Case for Biotech Growth Against Regeneron
Incyte is positioning itself as a strong contender for biotech growth, making its case against established players like Regeneron.
13 Jul, 17:37 — 13 Jul, 17:37
Sources
Showing 1 of 1 sources
